Andrea Fagiolini

Summary

Publications

  1. doi request reprint Prevalence, chronicity, burden and borders of bipolar disorder
    Andrea Fagiolini
    University of Siena, Department of Molecular Medicine and Clinical DAI Department of Mental Health, Viale Bracci 1, Siena 53100, Italy
    J Affect Disord 148:161-9. 2013
  2. doi request reprint The effects of undertreated chronic medical illnesses in patients with severe mental disorders
    Andrea Fagiolini
    Department of Neuroscience, University of Siena School of Medicine, Viale Bracci 1, Siena 53100, Italy
    J Clin Psychiatry 70:22-9. 2009
  3. doi request reprint Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder
    Andrea Fagiolini
    University of Siena School of Medicine, Division of Psychiatry, Department of Neuroscience, Siena 53100, Italy
    Expert Opin Pharmacother 11:1727-40. 2010
  4. doi request reprint Strategies for successful clinical management of schizophrenia with ziprasidone
    Andrea Fagiolini
    University of Siena School of Medicine, Department of Neuroscience, Viale Bracci 1, 53100 Siena, Italy
    Expert Opin Pharmacother 11:2199-220. 2010
  5. pmc Rediscovering trazodone for the treatment of major depressive disorder
    Andrea Fagiolini
    Division of Psychiatry, Department of Molecular Medicine, University of Siena School of Medicine, Viale Bracci 1, Siena, Italy
    CNS Drugs 26:1033-49. 2012
  6. doi request reprint Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice
    Andrea Fagiolini
    University of Siena, Departments of Mental Health and Molecular Medicine, Viale Bracci 1, Siena 53100, Italy
    Expert Opin Pharmacother 14:489-504. 2013
  7. doi request reprint Quality of life, anxiety and depression in sarcoidosis
    Arianna Goracci
    Psychiatry Division, Department of Neuroscience, University of Siena School of Medicine, Viale Bracci 1, 53100 Siena, Italy
    Gen Hosp Psychiatry 30:441-5. 2008
  8. doi request reprint Photosensitivity and panic-agoraphobic spectrum: a pilot study
    Letizia Bossini
    Department of Neuroscience, University of Siena, Italy
    Riv Psichiatr 48:108-12. 2013
  9. doi request reprint Aripiprazole for the treatment of bipolar disorder: a review of current evidence
    Andrea Fagiolini
    University of Siena School of Medicine, Department of Mental Health and Neuroscience, Siena 53100, Italy
    Expert Opin Pharmacother 12:473-88. 2011
  10. doi request reprint Off-label uses of trazodone: a review
    Letizia Bossini
    University of Siena, Psychiatry Division, Department of Neuroscience, Viale Bracci 1, 53100 Siena, Italy
    Expert Opin Pharmacother 13:1707-17. 2012

Detail Information

Publications14

  1. doi request reprint Prevalence, chronicity, burden and borders of bipolar disorder
    Andrea Fagiolini
    University of Siena, Department of Molecular Medicine and Clinical DAI Department of Mental Health, Viale Bracci 1, Siena 53100, Italy
    J Affect Disord 148:161-9. 2013
    ....
  2. doi request reprint The effects of undertreated chronic medical illnesses in patients with severe mental disorders
    Andrea Fagiolini
    Department of Neuroscience, University of Siena School of Medicine, Viale Bracci 1, Siena 53100, Italy
    J Clin Psychiatry 70:22-9. 2009
    ..Implementing behavioral interventions into clinical practice may help patients improve their overall health and prevent chronic medical conditions...
  3. doi request reprint Risperidone long-acting injection as monotherapy and adjunctive therapy in the maintenance treatment of bipolar I disorder
    Andrea Fagiolini
    University of Siena School of Medicine, Division of Psychiatry, Department of Neuroscience, Siena 53100, Italy
    Expert Opin Pharmacother 11:1727-40. 2010
    ..Risperidone long-acting injection (LAI) has proven efficacious for the maintenance phase of bipolar disorder and may mitigate the problem of nonadherence in the substantial group of patients for whom this is a significant concern...
  4. doi request reprint Strategies for successful clinical management of schizophrenia with ziprasidone
    Andrea Fagiolini
    University of Siena School of Medicine, Department of Neuroscience, Viale Bracci 1, 53100 Siena, Italy
    Expert Opin Pharmacother 11:2199-220. 2010
    ....
  5. pmc Rediscovering trazodone for the treatment of major depressive disorder
    Andrea Fagiolini
    Division of Psychiatry, Department of Molecular Medicine, University of Siena School of Medicine, Viale Bracci 1, Siena, Italy
    CNS Drugs 26:1033-49. 2012
    ..The recently approved prolonged-release formulation should provide further optimization of this antidepressant and may be useful for enabling an appropriate therapeutic dose to be administered with improved patient compliance...
  6. doi request reprint Asenapine for the treatment of manic and mixed episodes associated with bipolar I disorder: from clinical research to clinical practice
    Andrea Fagiolini
    University of Siena, Departments of Mental Health and Molecular Medicine, Viale Bracci 1, Siena 53100, Italy
    Expert Opin Pharmacother 14:489-504. 2013
    ..Its relatively favorable weight and metabolic profile, as well as the lack of appreciable activity at muscarinic cholinergic receptors and the sublingual administration are of clinical interest...
  7. doi request reprint Quality of life, anxiety and depression in sarcoidosis
    Arianna Goracci
    Psychiatry Division, Department of Neuroscience, University of Siena School of Medicine, Viale Bracci 1, 53100 Siena, Italy
    Gen Hosp Psychiatry 30:441-5. 2008
    ..This study sought to evaluate the quality of life and the presence of psychiatric disorders in patients with sarcoidosis...
  8. doi request reprint Photosensitivity and panic-agoraphobic spectrum: a pilot study
    Letizia Bossini
    Department of Neuroscience, University of Siena, Italy
    Riv Psichiatr 48:108-12. 2013
    ....
  9. doi request reprint Aripiprazole for the treatment of bipolar disorder: a review of current evidence
    Andrea Fagiolini
    University of Siena School of Medicine, Department of Mental Health and Neuroscience, Siena 53100, Italy
    Expert Opin Pharmacother 12:473-88. 2011
    ..several medications are available for the treatment of different phases of bipolar disorder, yet many of the drugs that are currently approved carry a substantial burden of side effects or do not lead all treated patients to remission...
  10. doi request reprint Off-label uses of trazodone: a review
    Letizia Bossini
    University of Siena, Psychiatry Division, Department of Neuroscience, Viale Bracci 1, 53100 Siena, Italy
    Expert Opin Pharmacother 13:1707-17. 2012
    ..More studies are necessary to investigate possible new therapeutic indications, and to scientifically demonstrate the risk/benefit ratio for the many conditions for which trazodone is used, but not approved by the FDA...
  11. doi request reprint Photosensitivity in panic disorder
    Letizia Bossini
    Department of Neuroscience, Psychiatry Division, University of Siena School of Medicine, Viale Bracci 1, Siena, Italy
    Depress Anxiety 26:E34-6. 2009
    ..The objective of this study is to evaluate abnormal light-related behavior in patients with panic disorder (PD)...
  12. doi request reprint Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Four case reports
    Federica Luchini
    Department of Psychiatry, Neurobiology, Pharmacology and Bio technologies, University of Pisa, Pisa, Italy
    J Nerv Ment Dis 201:36-42. 2013
    ..Our experience confirms the efficacy and safety of ECT in combination with BDZ as treatment of NMS and residual catatonia...
  13. ncbi request reprint The use of antidepressants in bipolar disorder
    Virginio Salvi
    Department of Neuroscience, University of Turin, Italy
    J Clin Psychiatry 69:1307-18. 2008
    ..Nevertheless, many clinicians continue to employ antidepressants, especially in the management of severe depression that is unresponsive to mood stabilizers alone...
  14. ncbi request reprint Quality of life and subthreshold affective symptoms
    Arianna Goracci
    Department of Neuroscience, Division of Psychiatry, University of Siena, Viale Bracci 1, Siena 53100, Italy
    Qual Life Res 14:905-9. 2005
    ..Our data suggests that subjects who report subthreshold affective symptomatology also report a low degree of enjoyment and satisfaction from life. The depressive aspects of the mood spectrum seem to have the greatest negative influence...